Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Lineage Therap ( (LCTX) ) has shared an update.
Lineage Cell Therapeutics has announced a registered direct offering to raise up to $66 million, involving healthcare-focused institutional investors and Broadwood Partners. The deal includes the sale of over 39 million common shares and warrants, with a potential additional $36 million from warrant exercises. The proceeds aim to support working capital and R&D. H.C. Wainwright & Co. is the exclusive placement agent for the offering, anticipated to close pending customary conditions and shareholder approval.
For an in-depth examination of LCTX stock, go to TipRanks’ Stock Analysis page.